Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Vivos Therapeutics (VVOS)

  • Business News
  • Nov. 19, 2025, 21:20 UTC
  • 13
  • 1 comments

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Market reaction Comment Full text

Zyversa Therapeutics Inc (ZVSA)

  • Business News
  • Nov. 19, 2025, 21:20 UTC
  • 23
  • 1 comments

ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results

Market reaction Comment Full text

Agilent Technologies Inc. (A)

  • Business News
  • Nov. 19, 2025, 21:15 UTC
  • 4
  • 0 comments

Agilent Technologies, Inc. - Agilent Announces Cash Dividend of 25.5 Cents Per Share

Market reaction Comment Full text

Baxter International Inc (BAX)

  • Business News
  • Nov. 19, 2025, 21:15 UTC
  • 5
  • 0 comments

Baxter - Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027

Market reaction Comment Full text

Vicarious Surgical Inc (RBOT)

  • Business News
  • Nov. 19, 2025, 21:15 UTC
  • 5
  • 0 comments

Vicarious Surgical Inc. - Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference

Market reaction Comment Full text

Vicarious Surgical Inc (RBOT)

  • Business News
  • Nov. 19, 2025, 21:15 UTC
  • 14
  • 1 comments

Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference

Market reaction Comment Full text

Baxter International Inc (BAX)

  • Business News
  • Nov. 19, 2025, 21:15 UTC
  • 15
  • 1 comments

Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027

Market reaction Comment Full text

Agilent Technologies Inc. (A)

  • Business News
  • Nov. 19, 2025, 21:15 UTC
  • 14
  • 1 comments

Agilent Announces Cash Dividend of 25.5 Cents Per Share

Market reaction Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • Business News
  • Nov. 19, 2025, 21:10 UTC
  • 11
  • 1 comments

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

Market reaction Comment Full text

OPKO HEALTH (OPK)

  • Business News
  • Nov. 19, 2025, 21:05 UTC
  • 6
  • 0 comments

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

Market reaction Comment Full text
  • Previous
  • 556
  • 557
  • 558
  • 559
  • 560
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191985)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin